MAGGI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 2.952
NA - Nord America 1.057
AS - Asia 166
AF - Africa 9
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.188
Nazione #
IE - Irlanda 2.267
US - Stati Uniti d'America 1.055
IT - Italia 263
GB - Regno Unito 147
CN - Cina 104
FR - Francia 73
DE - Germania 67
IN - India 42
GR - Grecia 36
UA - Ucraina 24
FI - Finlandia 21
CZ - Repubblica Ceca 19
SE - Svezia 14
BE - Belgio 7
HK - Hong Kong 6
AT - Austria 5
NL - Olanda 4
BD - Bangladesh 3
CM - Camerun 3
PH - Filippine 3
TR - Turchia 3
BR - Brasile 2
CA - Canada 2
CD - Congo 2
DK - Danimarca 2
ET - Etiopia 2
HU - Ungheria 2
SG - Singapore 2
UG - Uganda 2
CO - Colombia 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 4.188
Città #
Dublin 2.266
Chandler 143
Boardman 141
New York 97
Jacksonville 84
Princeton 76
Roxbury 75
Cambridge 51
Pune 40
Naples 36
Bremen 32
Medford 30
Ann Arbor 26
Des Moines 23
Caserta 20
Beijing 18
Jinan 18
Wilmington 18
Brno 15
Napoli 15
Helsinki 14
Bari 13
Hebei 10
Messina 9
Munich 9
Redwood City 8
Ashburn 7
Boydton 7
Brussels 7
Padova 7
Hong Kong 6
Nanjing 6
Shenyang 6
Torre Del Greco 6
Zhengzhou 6
Hangzhou 5
Lappeenranta 5
Los Angeles 5
Milan 5
Nanchang 5
Ningbo 5
Paris 5
Rome 5
Vienna 5
Woodbridge 5
Brdo 4
Cava Dei Tirreni 4
Limbiate 4
Pittsburgh 4
Washington 4
Amsterdam 3
Catania 3
Dearborn 3
Dhaka 3
Florence 3
Maletto 3
Monza 3
Norwalk 3
Pizzo 3
Taizhou 3
Addis Ababa 2
Ancona 2
Aversa 2
Barlassina 2
Budapest 2
Caivano 2
Campi Bisenzio 2
Casoria 2
Cerro Maggiore 2
Changchun 2
Changsha 2
Chengdu 2
Ciampino 2
Genoa 2
Gunzenhausen 2
Haikou 2
Hanover 2
Heilbronn 2
Istanbul 2
Juelsminde 2
Kinshasa 2
Kunming 2
Lanzhou 2
Massa 2
Menlo Park 2
Porto Torres 2
Queens 2
San Mateo 2
Sant'Antimo 2
Tianjin 2
Toronto 2
Turin 2
Xi'an 2
Acireale 1
Acton 1
Alghero 1
Alpharetta 1
Antea 1
Atlanta 1
Aydin 1
Totale 3.518
Nome #
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 70
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. 62
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 61
[Acquired immunodeficiency syndrome and pulmonary Mycobacterium xenopi infection. Role of computerized tomography] 55
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 50
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study 50
Alexithymia is linked to neurocognitive function independently of sociodemographic and clinical predictors. A multicentric HIV cohort study 48
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study. 43
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 43
Reazione di ipersensibilità ad abacavir associata a test HLAB5701 falsamente negativo al basale, in paziente HIV naive al trattamento antiretrovirale. 38
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 38
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 37
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 37
Weight gain in dolutegravir containing regimens in the observational SCOLTA cohort. 36
Evaluation of lipid profile in HIV naive patients, treated by TAF-based regimens. 35
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy 35
Archi-Prevaleat project. A National Register of color-Doppler ultrasonography of the epi-aortic vessels in Patients Living with HIV. 34
Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV. 34
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 33
A comprehensive development agenda on tenofovir alafenamide in clinical practice 33
Squillace N, Menzaghi B, Migliorino GM, De Socio GV, Passerini S, Martinelli C, Mameli MS, Maggi P, Falasca K, Cordier L, Celesia BM, Salomoni E, Di Biagio A, Pellicanò G, Bonfanti P. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide and cholesterol increase: impact on cardiovascular risk assessment. Journal of HIV and Ageing. 33
Dolutegravir safety in a real-life setting: results Title from the SCOLTA cohort 33
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 33
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients 33
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 32
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study 31
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 29
Hyperglycaemia on admission to hospital and COVID-19 29
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA 28
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 28
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 27
Implications of AB0 blood group in hypertensive patients with covid-19 27
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 25
Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis 25
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 24
Smoking habits in HIV-infected people from Italy: a cross-sectional analysis of the STOPSHIV cohort 24
Cardiovascular risk and dyslipidemia among persons living with HIV: A review 24
Ruolo della diagnostica con Fibroscan nella valutazione della fibrosi epatica in pazienti HIV-positivi. Confronto tra soggetti monoinfetti versus coinfetti 23
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 23
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 23
Safety and metabolic impact of darunaviur/cobicistat in a real-life setting. Results from the SCOLTA study cohort. 23
Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control? 23
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 23
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 22
Adipocyte differentiation of 3T3-L1 cells under TAF, TDF and INSTIs selective challenge: an in vitro model 22
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 21
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use. 21
Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection 21
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 20
Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project 20
Sunscreen ingredients in plasma: a threat for drug-drug interactions and toxicity among patients living with HIV? 20
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 20
Editorial - Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents. 20
Factors associated with hospital admission for COVID-19 in HIV patients. 20
Dynamics of Lipid Profile in Antiretroviral-Naïve HIV-Infected Patients, Treated with TAF-Based Regimens: A Multicenter Observational Study 20
Decrease of renal function in HCV and HIV/HCV-infected patients with telaprevir-based therapy 19
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study 19
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV-specific risk factors; the Archi-Prevaleat project 18
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 18
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 18
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 18
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 17
A color doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1 positive patients 17
Fatty Liver in HIV-Infected Persons 17
. Prevaleat study (Premature Vascular Lesions and Antiretroviral Therapy). A comparative study between patients treated with PI-including regimens vs NNRTI-including regimens 16
A Cyanobacterium-Like Body found in the stools of an HIV+ patient with diarrhoea 16
Accettabilità del condom: studio su una coorte di tossicodipendenti e loro partners 16
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible From the STOPSHIV Project Cohort. 16
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 16
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 15
Abnormalities of abdominal wall: a case of venous displasia between external mammary common femoral veins and right iliac axis with varicocele 15
. Cutaneous reactions in HIV-1 positive patients treated with enfuvirtide 15
Enhancing care for people living with HIV: current and future monitoring approaches. 15
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 15
Prevalence and Risk Factors for Significant Liver Fibrosis in Patients with HIV Infection 15
Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients 15
Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis. Prevalence of Human Immunodeficiency virus, Hepatitis B Virus and Hepatitis C Virus among dialysis patients. 14
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naïve HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 14
A greater prevalence of X4 viruses in HIV type 1 intravenous drug users reflects a "CD4+ effect" 14
Effects of therapy with maraviroc on the carotid intima media thickness in HIV-1/HCV Co-infected patients 14
Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience 14
A color-doppler ultrasonographic comparative study between patients treated with PI-including regimens vs NNRTI-including regimens (Prevaleat study). 14
The role of immune reconstitution in the onset of subclinical atheromasic lesions 14
. Long term non progressors among IVDA: behavioural, clinical and virological aspects 13
A retrospective study on non transfusional HCV hepatitis in hemodialized patients 13
Movement disorders in patients with cerebral toxoplasmosis and AIDS 13
A nodular pulmonary lesion due to Linguatula serrata in an HV-positive man 13
Long-term administration of Inosine-Pranobex (INPX) in anti-HIV asymptomatic carriers. Preliminary results of a controlled study 13
Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years 13
Novel antiretroviral drugs and renal function monitoring of HIV patients 13
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 13
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 13
Effectiveness of first-generation HCV protease inhibitors: Does HIV coinfection still play a role? 13
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 13
BONE TURN-OVER MARKERS IN HIV POSITIVE PATIENTS AFTER HAART: TENOFOVIR (TDF) plus EMTRICITABINE (FTC) plus ATAZANAVIR/RITONAVIR (ATV/R)-VS.-TDF plus FTC plus EFAVIRENZ (EFV): RESULTS OF INCA TRIAL 12
Precocious lesions of the carotid vessels in HIV-1 patients treated with protease inhibitors 12
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study 12
Bilateral saphenous vein thrombosis associated with a triple-drug regimen including nelfinavir (NFV) in a HIV-patient: Case report. 12
A case of human brucellosis caused by accidental injection of animal vaccine 12
B-mode Ultrasound Study of Carotid Plaques in HIV-positive Patients to Detect the Presence of Inflammatory Endothelial Lesions 12
Totale 2.401
Categoria #
all - tutte 31.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0 0 0 0 0 0 0 0 0 0 6 17
2019/2020206 49 26 14 12 9 7 32 20 7 2 17 11
2020/2021337 6 7 10 36 86 33 35 32 8 39 38 7
2021/2022456 6 16 4 9 149 9 19 11 22 17 27 167
2022/20232.362 102 18 12 13 103 39 320 49 1.668 10 10 18
2023/20241.230 30 55 45 164 698 172 23 11 15 17 0 0
Totale 4.647